GLP-1 vs GIP Agonists: Understanding the Difference

A clear comparison of single-pathway GLP-1 medicines and dual GIP/GLP-1 agonists to help clinics and patients choose the right approach.

Master Pharm Professional Services TeamJuly 10, 20265 min read

GLP-1 vs GIP Agonists: Understanding the Difference

Not all weight loss peptides work the same way. GLP-1 agonists like Semaglutide target one receptor pathway. Dual agonists like Tirzepatide activate both GLP-1 and GIP receptors. Understanding this difference helps clinics explain why multiple formulary options exist.

Quick Comparison

GLP-1 only (Semaglutide): Most established pathway; strong appetite suppression; broad clinical familiarity
Dual GIP/GLP-1 (Tirzepatide): Additional metabolic signaling; may suit patients needing dual-pathway support
Triple agonist (Retatrutide): Adds glucagon pathway for advanced programs
Selection depends on patient profile, protocol stage, and physician assessment — not a one-size-fits-all choice

Browse Formulary Contact Our Team

Peptides for Weight Loss: What You Need to Know

Medicine Guides

Jul 10, 20268 min read

Peptides for Weight Loss: What You Need to Know

A complete guide to weight loss peptides — how GLP-1 medicines work, which compounds clinics use, and how to understand Semaglutide, Tirzepatide, and Retatrutide.

Read article →